Abbott Raises 2026 Profit Forecast on Diagnostics, Heart Devices Strength
Abbott raised its 2026 profit forecast after beating quarterly estimates, driven by strong demand in its acquired cancer diagnostics business and medical devices segments, offsetting declines in COVID
reuters · 2026-07-16 04:33 UTC